ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

1,972.00
47.00 (2.44%)
Last Updated: 16:27:53
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  47.00 2.44% 1,972.00 1,971.00 1,973.00 1,977.00 1,931.00 1,937.00 146,551 16:27:53
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 22.69 4.36B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,925p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,711.00p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.36 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.69.

Hikma Pharmaceuticals Share Discussion Threads

Showing 101 to 122 of 1875 messages
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
03/10/2011
20:54
A big pharma will licence there drugs or will do a takeover of Verona pharma listed on Aim.
aimshares
14/9/2011
09:48
Bouncing from 550 and this could be buying opp but for the very brave only as the troubles in Libya, Egypt, Syria and Middle East may still affect the possible recovery. There is an article in The Telegraph today titled "Libya and Egypt unrest hurts Hikma Pharmaceuticals". Worth reading.


Nevertheless looks like a possibility of a double bottom to me and worth trying with the stop around 530.

odys2
03/8/2011
10:20
been battered - buying opp now?
chc15
13/6/2011
13:02
I am out as planned.
odys2
13/6/2011
12:15
Does anybody know why the recent drop on quite high volume? Seems to me that there is no obvious reason. Nevertheless I am going to do a runner if the share price goes below the expected support at 800.
odys2
18/3/2011
18:41
Broker upgrade today
nellie1973
17/3/2011
14:21
Topped up as planned.
odys2
15/3/2011
13:19
Hikma will announce its preliminary results for the year ended 31 December 2010 on Wednesday 16 March 2011.
Panic selling all over the stock market is understandable after the earthquake. Support at 700 is still holding.
Top up time? Or would it be better to wait till tomorrow for the preliminary results reaction first? I'd rather wait for a convincing buy signal.

odys2
28/1/2011
12:18
worries over middle-east street protests?fig.
fig1
05/1/2011
15:14
Going well today
hannabella
12/11/2010
16:13
Naked Trader writes today:


"Stocks often fall on a statement day even if the statement is good.

It's often profitable to buy in once the profit takers have gone. Either late the same day or a couple of days later.

So I just bought some more Hikma (HIK) for a spreadbet fiver at 748 to add to the ones I got in the 720s. It looks like it might have bottomed and it climbing back up. The statement didn't have any horrors and the longer term uptrend is still strong, so I've bought on the weakness. Maybe I should have waited longer - We shall see! Target 850 stop 720."

odys2
12/11/2010
09:30
taken off all stop and topped up :) , bring it on mm . u aint geting non of mine this time .

will hold it till 9.50

robrah
12/11/2010
08:46
Nothing wrong with the interim management statement. Some top up opportunities this morning.
odys2
03/11/2010
16:07
Robbie Burns is still holding Hikma. His todays comments from the Naked Trader website:

"Hikma came back a bit after the big rise on the acquisition news - been a nice one so far and the rise looks set to continue."

odys2
03/11/2010
00:14
Yes Robrah, looks like another tree shake...
Now something more - a quotation from Ukcitymedia - Newspaper share tips:

"Pharma giant Hikma announced at the end of last week that it will pay $112m for the US company Baxter. This is equivalent to around 7 times earnings, which looks good value for the pharmaceutical sector. Brokers believe Hikma shares are 23 times this year's earnings and so the Times says that they are up with events."

odys2
02/11/2010
15:48
seems like MM trying to drop it again but not letting this go this time . must be somemore news tomorrow .

in fact looking for a price to top up .

robrah
02/11/2010
00:00
Short article by topnews.co.uk published yesterday

quotes:
"Hikma Pharmaceuticals is said to be listed on the London Stock Exchange, as after the acquirement it has now become the 10th to the second biggest supplier of the drugs in the US with a 15% market share."

"Even after the $112m deal, Hikma is left with $500m which it intends to spend on facilities and expansions"

odys2
01/11/2010
09:26
Robrah - You are completely correct in your assumption, somebody always knows. It has always been the way and always will be. "Fair"...... not really, but that is the name of the game I'm afraid. Seen this a zillion times before.
gorilla36
29/10/2010
09:53
Most probably market makers collected shares yesterday to sell them dearly today.
odys2
29/10/2010
08:48
the massive fall yesterday 30 p and the massive jump today 50 p .

I susupect someone had this news before it was made public this morning .

it is not fair the way this work. :(

robrah
29/10/2010
07:49
As per todays RNS:


"The acquisition of Multi-Source Injectables:

� Brings close to $180 million in annual revenue, significantly enhancing the
scale and scope of Hikma's global Injectables platform

� Adds a high-quality, complementary injectables portfolio including
excellent critical care products and DEA controlled substances

� Positions Hikma as the second largest injectables supplier in the US1 with
a combined market share of more than 15%

� Brings well qualified and experienced operational and sales teams with
excellent technical skills and customer relationships

� Increases Hikma's high quality injectables manufacturing capacity and
distribution capabilities"

odys2
13/10/2010
22:13
It could be time to buy. The Naked Trader - Robbie Burn's is in. He is usually right. His followers will come to buy as well.

The quote:
"I also nabbed some Hikma (HIK) - time I got myself a bit of exposure to this sector. Fundamentals look good but even better is the lovely strong uptrend that is kicking skywards. This one's on a spreadbet for a tenner at 720. Target 800 stop 705."

odys2
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older

Your Recent History

Delayed Upgrade Clock